As non-alcoholic fatty liver disease is increased in PCOS we hypothesized that this, and other important liver pathways including metabolic function, insulin–like growth factor (IGF) and steroid receptivity, would be affected. The gene discussed is IGF1; the disease is metabolic dysfunction-associated steatotic liver disease.